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Preventive mitochondrial replacement 
Leslie E Orgel 
Techniques used recently to clone a sheep generate 
chimeras with the genome of the donor cell and mainly 
the mitochondria of the acceptor egg. The use of the 
same techniques should allow a mother carrying a 
mitochondrial defect to bear a normal child with 
normal mitochondria. 
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The recent successful cloning of a sheep [l], and the con- 
sequent perception that the cloning of a person may be 
possible, has led to extensive discussion of the ethical 
issues involved. Benefits to humankind such as simplified 
drug development and the production of high milk produc- 
ing herds have been arrayed against the potential horrors of 
cloning animals and humans. One potential application of 
cloning techniques has been overlooked in the public 
debate, however, namely the production of single-copy 
chimeras in which the nuclear genome is identical to that 
which would result from a normal pregnancy but the 
mitochondrial genome comes from an independent donor. 
Mitochondria are intracellular organelles responsible for the 
synthesis of ATT’, the major energy source for biochemistry. 
Table 1 
Some inherited diseases of the human mitochondrial genome. 
Disease 
Cytochrome c oxidase deficiency 
Symptoms 
Loss of appetite, muscle 
weakness, lactic acidosis 
Hypertrophic cardiomyopathy Shortness of breath, chest 
pain, fainting episodes 
Kearns-Sayre syndrome Eye-movement disorders, 
heart arrhythmias 
Mitochondrial encephalomyopathy Seizures, stroke-like episodes, 
lactic acidosis 
Myoclonic epilepsy Seizures, dementia, hearing 
loss, loss of balance 
Pyruvate dehydrogenase deficiency Lactic acidosis, central nervous 
system degeneration 
They have a small DNA genome that encodes proteins 
essential for mitochondrial function. There are a substantial 
number of rare diseases that are caused by mutations in the 
mitochondrial genome (Table 1). According to the United 
iLlitochondria1 Disease Foundation, about one person in 
10 000 carries a mitochondrial mutation (see The United 
hlitochondrial Disease Foundation internet site, http://bio- 
chemgen.ucsd.edu/UMDF/About~litoDisease.htm). The 
mitochondria of a fertilized egg are derived from the 
mother, with no paternal contribution. Consequently, mito- 
chondrial diseases are transmitted maternally. The follow- 
ing steps might enable a mother carrying a clinically 
significant mitochondrial mutation to produce a normal 
child (for related ideas see [IQ]). First, initiate a normal 
pregnancy. Second, harvest embryonic cells. Third, fuse 
one of the embryonic cells as donor to an acceptor egg with 
normal mitochondria from which the nucleus has been 
F igure 1 
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Transfer of nucleus (purple) from donor cell together with a small 
number of abnormal mitochondria (green) into an enucleated egg 
which has many normal mitochondria (red). The nucleus is removed 
from the egg using a micropipette, and fusion of the donor cell to the 
egg is induced by electrical pulses [l]. 
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removed (Fig. l), using techniques similar to those estab- 
lished for sheep, if this can be done in humans. Finally, 
implant the egg in the original mother. 
This sequence of procedures should result in an individ- 
ual who would differ from the individual who would have 
arisen from a normal pregnancy only in having a mito- 
chondriai pool containing both donor and acceptor mito- 
chondria. The choice of donor cell type should make it 
possible to obtain a chimera in which the majority of the 
mitochondria come from the egg. 
hlitochondrial replacement might fail for a number of 
reasons, for example if mutant mitochondria replace 
normal mitochondria during development. Furthermore, 
in ails fertilization methods might make it unnecessary to 
harvest embryonic cells, or make it possible to transplant 
nuclei between unfertilized oocytes [4] and thus to elimi- 
nate completely the need for cloning procedures. In view 
of these uncertainties, and because the number of people 
who would be helped is small, mitochondrial replacement 
is not a justification for the extension of cloning to 
humans. Nevertheless, mitochondrial replacement is a 
topic that could be considered in the ongoing debate on 
the ethics of cloning. 
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